| http://dbpedia.org/ontology/abstract
|
Invitae Corp. is a biotechnology company t … Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.care AI startup Ciitizen for $325 million.
|
| http://dbpedia.org/ontology/foundingYear
|
2010
|
| http://dbpedia.org/ontology/headquarter
|
http://dbpedia.org/resource/San_Francisco%2C_California +
|
| http://dbpedia.org/ontology/industry
|
http://dbpedia.org/resource/Genetic_testing +
|
| http://dbpedia.org/ontology/keyPerson
|
http://dbpedia.org/resource/Chief_executive_officer +
|
| http://dbpedia.org/ontology/netIncome
|
6.089E8
|
| http://dbpedia.org/ontology/revenue
|
2.796E8
|
| http://dbpedia.org/ontology/revenueYear
|
2020
|
| http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Invitae-logo.png?width=300 +
|
| http://dbpedia.org/ontology/wikiPageExternalLink
|
https://finance.yahoo.com/quote/nvta +
, https://www.invitae.com/en +
, https://www.google.com/finance/quote/NVTA:NYSE +
, https://www.nyse.com/quote/XNYS:NVTA +
, https://www.invitae.com/en/ +
|
| http://dbpedia.org/ontology/wikiPageID
|
1666393
|
| http://dbpedia.org/ontology/wikiPageLength
|
10593
|
| http://dbpedia.org/ontology/wikiPageRevisionID
|
1099089388
|
| http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/Combinatorial_chemistry +
, http://dbpedia.org/resource/Genetic_testing +
, http://dbpedia.org/resource/Corporate_spin-off +
, http://dbpedia.org/resource/Pediatric +
, http://dbpedia.org/resource/Postnatal +
, http://dbpedia.org/resource/Chief_executive_officer +
, http://dbpedia.org/resource/Acacia_Research_Corporation +
, http://dbpedia.org/resource/Mukilteo%2C_Washington +
, http://dbpedia.org/resource/San_Francisco%2C_California +
, http://dbpedia.org/resource/Category:Companies_listed_on_the_New_York_Stock_Exchange +
, http://dbpedia.org/resource/Prenatal_diagnosis +
, http://dbpedia.org/resource/Genomic_Health +
, http://dbpedia.org/resource/Category:Research_support_companies +
, http://dbpedia.org/resource/Human_genome_sequence_map +
, http://dbpedia.org/resource/Category:Microarrays +
, http://dbpedia.org/resource/Miscarriage +
, http://dbpedia.org/resource/Oncology +
, http://dbpedia.org/resource/Single-nucleotide_polymorphism +
, http://dbpedia.org/resource/Caltech +
, http://dbpedia.org/resource/United_States_Department_of_Defense +
|
| http://dbpedia.org/property/hqLocation
|
San Francisco, California, U.S.
|
| http://dbpedia.org/property/industry
|
Genetic testing
|
| http://dbpedia.org/property/keyPeople
|
Kenneth D. Knight
|
| http://dbpedia.org/property/logo
|
Invitae-logo.png
|
| http://dbpedia.org/property/name
|
Invitae Corp.
|
| http://dbpedia.org/property/netIncome
|
-US$608.9 million
|
| http://dbpedia.org/property/netIncomeYear
|
2020
|
| http://dbpedia.org/property/revenue
|
2.796E8
|
| http://dbpedia.org/property/revenueYear
|
2020
|
| http://dbpedia.org/property/tradedAs
|
NYSE:NVTA
|
| http://dbpedia.org/property/website
|
https://www.invitae.com/en +
|
| http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Missing_information +
, http://dbpedia.org/resource/Template:Start_date_and_age +
, http://dbpedia.org/resource/Template:Citation_needed +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Infobox_company +
, http://dbpedia.org/resource/Template:Short_description +
|
| http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Companies_listed_on_the_New_York_Stock_Exchange +
, http://dbpedia.org/resource/Category:Microarrays +
, http://dbpedia.org/resource/Category:Research_support_companies +
|
| http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Invitae?oldid=1099089388&ns=0 +
|
| http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Invitae-logo.png +
|
| http://xmlns.com/foaf/0.1/homepage
|
https://www.invitae.com/en +
|
| http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Invitae +
|
| http://xmlns.com/foaf/0.1/name
|
Invitae Corp.
|
| owl:sameAs |
http://dbpedia.org/resource/Invitae +
, http://www.wikidata.org/entity/Q5150796 +
, https://global.dbpedia.org/id/4i1bp +
|
| rdf:type |
http://dbpedia.org/ontology/Company +
, http://www.wikidata.org/entity/Q24229398 +
, http://dbpedia.org/ontology/Organisation +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#Agent +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#SocialPerson +
, http://www.wikidata.org/entity/Q43229 +
, http://www.wikidata.org/entity/Q4830453 +
, http://schema.org/Organization +
, http://dbpedia.org/ontology/Agent +
|
| rdfs:comment |
Invitae Corp. is a biotechnology company t … Invitae Corp. is a biotechnology company that was created as a subsidiary of Genomic Health in 2010 and then spun-off in 2012. In 2017, Invitae acquired Good Start Genetics and CombiMatrix. In 2020, Invitae announced the acquisition of ArcherDX for $1.4 billion. In 2021, Invitae announced the acquisition of health care AI startup Ciitizen for $325 million.care AI startup Ciitizen for $325 million.
|
| rdfs:label |
Invitae
|
